Semaglutide as a promising treatment for metabolic dysfunction‑associated steatotic liver disease. Journal of Medical Science, Poznań, Poland, v. 94, n. 1, p. e1219, 2025. DOI: 10.20883/medical.e1219. Disponível em: https://jmsnew.ump.edu.pl/index.php/JMS/article/view/1219. Acesso em: 1 jul. 2025.